Company News, Media 14 Jun 2024 Petra Capital Research Report | June 2024 Petra Capital has released research report, forecasting Orthocell’s potential to reach A$1.28 per share. Orthocell
Company News 11 Jun 2024 Orthocell applies for TGA market approval for SmrtGraft™ Orthocell has applied to the Therapeutic Good Administration (TGA) for Australian market approval for its SmrtGraft™ tendon repair device, in… Orthocell
Company News 30 Apr 2024 Remplir™ nerve repair study published in peer-reviewed clinical journal Orthocell has announced that results from the Remplir™ nerve regeneration clinical trial have been published in a high profile clinical… Orthocell
Company News 15 Apr 2024 Orthocell receives $3.05m R&D tax incentive refund Orthocell has announced that it has received a Research and Development (R&D) Tax Incentive refund of A$3,051,483 for the financial… Orthocell
Company News 08 Apr 2024 Quarterly Report – Period To 31 March 2024 Orthocell has today published its Quarterly Report for the period ended 31 March 2024. Orthocell
Media 26 Mar 2024 Proactive Interview with Paul Anderson Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation… Orthocell
Company News 25 Mar 2024 Orthocell Successfully Completes Surgeries for Remplir™ US Market Authorisation Orthocell has announced that it has successfully completed the first stage of the Remplir™ US 510(k) market authorisation nerve repair… Orthocell
Media, Video 23 Feb 2024 Proactive | Interview with CEO Paul Anderson Orthocell CEO Paul Anderson spoke with Proactive about the Company’s recent strategic placement of $3.5 million, adding prominent investors to… Orthocell
Media 22 Feb 2024 The West Australian | Chris Ellison, Rod Jones and the McCuskers jump into Orthocell Orthocell’s Company-led strategic placement has been reported in The West Australian newspaper, in an article by Senior Business Report Sean… Orthocell
Company News 22 Feb 2024 Orthocell Completes $3.5M Strategic Placement Orthocell has today announced that it has completed a Company-led Strategic Placement to raise $3.5 million. Orthocell